Clinical Trials Browser

Phase 3 × Lymphoma, Extranodal NK-T-Cell × Doxorubicin × Clear all

NCT02359162 2018-05-09

Efficacy and Safety Study of P-Gemox vs.EPOCH as First-line Chemotherapy to Treat NK/T-cell Lymphoma With Early Stage

Phase 3 Terminated

Lymphoma, Extranodal NK-T-Cell

NCT00725231 2012-05-07

A-CHOP-14

Phase 3 Unknown

Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Lymphoma, Extranodal NK-T-Cell